| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |